Skip to main content

and
  1. No Access

    Article

    Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial

    Internal mammary lymphadenopathy (IML) plays a role in breast cancer stage and prognosis. We aimed to evaluate method of IML detection, how IML impacts response to neoadjuvant chemotherapy (NAC), and oncologic...

    Mara A. Piltin DO, FACS, Peter Norwood PhD, Velle Ladores BS in Annals of Surgical Oncology (2024)